ACTC waiting on news

ACTC's Rabin and Matt Vicent stated China's joint venture is in advanced state of discussion negotiation. I'm thinking the deal will get done sometime before the end of the year.
Reverse split before July.
20% improvement in eye vision with the injection of 50,000 stem cells. What will be in the % improvement with 100,000 stem cells, that will be what the next patients will get.

There conference call gave me the confidence to buy more shares.

With a joint venture, published results and ensuing media coverage for SMD [any day] and Dry AMD [June] this will be a 10 bagger.

Geron was up 3 cents and closed at $1.73 volume was 405,346. The three month avg. volume is 892,535. Waiting for the deal. Waiting for results.

Good luck in this rigged casino,

ACTC up a little. How's Marcus Hilton doing?

ACTC closed up a little at 0.084 on 5.8 million shares. Three month avg volume is 12.5 million shares.
Marcus Hilton had stem cells injected into his eye about 12 weeks ago. Can he see better?

Geron closed at $1.70 same as Wed. volume was 485,500 shares. Three month volume is 943,845 shares. The volume is just so low, no interest, no news, no deal.

Good luck in this rigged casino,

ACTC webcast company moving forward

I listened to the webcast. ACTC is moving forward with the reverse stock split. Phase 1/2 trials, in a few weeks, will be injecting 100,000 cells up from 50,000 cells. They had good results from 50,000, hopefully results will be even more positive [the blind will see]. Stock is down a little. Still have a good feeling about this company. Time will tell if I'm right or if it's just early signs of dementia.

Good luck in this rigged casino,

ACTC Announces Webcast today at 12:15PM

04-26-2012 at 12:15PM, ACTC presentation will cover corporate overview. Pre-clinical programs summary. RPE clinical program update and FDA planning for Phase 2. Financial Overview. Strategic and Corporate opportunities.
ACTC is up a little. Lets see if this presentation will move the stock up or down

Good luck in this rigged casino,

Geron closes up $1.70

Gereon closed up four cents at $1.70 on 620,096 shares. Three month avg. volume is 943,413.
May 2 at 4:30PM a live audio only webcast on Geron's 1st quarter financial results. Again hoping for a DEAL. Have got a bad feeling Geron will get no upfront money from there stem cell business. With no money from sale or partnership, look for Geron to sell some shares in 2013. The four Phase 2 trial ending this year will make or break Geron.

Good luck in this rigged casino,

May 2nd Geron's First Quarter Financial Results

Geron will announce its financial results for the first quarter eneded March 31, 2012 on Wednesday, May 2, 2012. A live audio only webcast at 4:30PM. Hoping for some good news, a DEAL for the stem cell business. I'll be listening. The Geron shareholder meeting will be webcast 5-17-21.

Good luck in this rigged casino,

ACTC Approved to Increase RPE Dosage for SMD Patients

ACTC announces approval to increase RPE dosage for Stargardt's disease patients in U.S. Trials. Robert Lanze MD ACT's chief scientific officer commented. "We are gratified to be moving to the next stage in both of our SMD trials. We remain very encouraged by the preliminary data in the first SMD patients treated with the lowest dose of RPE cells. We are doubling the number of cells [too 100,000cells]. "
SMD programs have been granted "orphan medicinal product designation in both US & Europe. The stock is up a little. This is good news ACTC is moving forward. Still have a good feeling about this company.

Good luck in this rigged casino,      

What is Geron really worth?

$1.64 was the close today. The following is from Seeking alpha by Jamie Moye. Geron has telomerase licensing deals with Merck and with Sienna Cancer Diagnostics. The comany has no debt and enough cash in the bank to run its trials and research for the next two years. Without any FDA approvals placing a value on its products, and thus the potential value of its stock, it's truly like throwing knives in the dark, but the potential value is so astronomical that this stock must have the best risk reward ratio in the field of biotech. That was written June 12, 2009. Now in less then 9 months we will know if Geron has a future and if I'm broke or rich.

Good luck in this rigged casino,

Review on Geron and ACTC

Geron has 6 Phase 2 trials on going. Four with Imetelstat: Breast Cancer, Non-Small Cell Lung Cancer, Essential Thrombocythemia, and Multiple Meloma. These four will have results by the end of this year, Dec. 2012. Two trials with GRN1005: Breast Cancer with metastases to the brain and Non-small cell lung cancer with metastases to the brain. These two will have results by the end of the 2Q of 2013.
If the results are positive, showing efficacy of only 10% that would be great news. I think 15% is possible judging by the Phase I trials. On the four Phase II trials ending this year, the small cell lung cancer efficacy of 2 to 3 months would be great news. I put a big bet on Geron. If I'm right on the Imetelstats and they work I'll be rich, if I'm wrong I'll be working till I drop dead.

ACTC:
With Geron out of the stem cell business. I brought some ACTC. They have Phase 1/2 trials going on now. Stargardt's Macular Dystrophy & Dry Age-Related Macular Degeneration. Human embryonic stem cell are injected in the eye. If it works the patient's vision will improve. I have a good feeling about this company.

Both company's need money badly and soon.

Always remember you can lose all your money in any stock.

Good luck in this rigged casino,

Geron and ACTC both up

The Market liked what Graham Cooper said today. You can listen to the webcast by going to Geron's website, click Events. Geron closed up 8 cents at $1.67 on good volume 1.3 million shares. The three month avg. is 940,252. If we can get more volume with a raise in price, just maybe we can hit $2.00.

ACTC closed up a little at 0.0839 on 3.9 million shares. Three month avg. volume is 15 million shares.
I have a good feeling about this company. I hope it's not early dementia on my part.

Good luck in this rigged casino,

Geron Webcast Nothing New

I listened to Graham Cooper, Geron's new CFO and there was nothing new. Results from four phase two trials at the end of this year and results from two phase two GRN 1005 trials in 2Q 2013. They have money for 2 years. If the trials have good results, we'll be in the money, big time. If the trials have poor results, we'll be broke, out of business. Geron up to $1.66 which is good, volume is low. It's wait and see.

ACTC is up on the news of third Dry AMD patient treated in Clinical Trial. Chief Scientific Officer Robert Lanza MD stated, "We are extremely pleased with the progress being made in all three of our clinical trials here in the US and the UK.

Good luck in this rigged casino,

ACTC Announces Third Dry AMD Patient Treated

April 20th, ACTC Announces third Dry AMD patient treated in Clinical trial. Robert Lanza MD, ACT's chief scientific officer stated, "We are extremely pleases with the progress being made in all three of our clinical trials here in the US and the UK.   ACTC is up a little today

Geron webcast at 10:30AM today is also up. Hoping for some thing good. Please Chip say it, a deal!

Good luck in this rigged casino,

Geron webcast Friday

Geron will be presenting at the Future Leaders in the Biotech Industry Conference in New York City at 10:30AM. It will be webcast. Chip please say some thing postive.  Geron closed up 4 cents at $1.59 on 714,000 shares. The three month avg. volume is 935,354 shares.
Seeking Alpha had  4 good reasons to buy Geron, "Thursday Shows Why Investors Own Biotechs Stocks" stated Geron was a high risk/high reward stock. The 4 reasons I've stated here before more or less.

Good luck in this rigged casino,

Geron and ACTC no news

This Friday at 10:30AM Geron will be presenting at the Future Leaders in the Biotech Industry Conference. I'm hoping for some kind of good news. The price and volume say no news.
Geron closed down 5 cent at $1.55 on only 385,401 shares. The three month avg. is 948,979 shares.

ACTC was down a little closing at 0.0829 on 2.4 million shares. Three month avg. volume is 15.2 million shares.

Good luck in this rigged casino,

Geron will webcast Friday 10:30AM

Geron at Future Leaders in the Biotech Industry Conference, Friday 10:30AM will be webcast.
Geron is up 3 cents at $1.58, time 12PM Tue. low volume. Hoping for good news.

ACTC down below 8 cent for a while.

Good luck in this rigged casino,

Low volume Geron & ACTC

Low volume, no news, no interest.

Geron closed up a little at $1.555 on only 308,517 shares, three month avg. volume is 959,639 shares. 4-27-2012 earnings. Dec 2012 results from 4 phase two trials will make or break this company.

ACTC closed up a little at 0.0837 on only 6 million shares. Three month avg. volume is 15.5 million shares. April 26th earnings webcast.

Good luck in this rigged casino,

ACTC first time Webcast Annual Shareholders Meeting

ACTC will Webcast 2012 Annual Shareholders Meeting on April 26th at 12PM. First time webcast meeting might be due to some big announcement. How this, one of the formerly blind Stargardt's patient reading the proxy vote results. That would be something!

Good luck in this rigged casino,

South Korea Stem Cell Investment in Geron?

That's the rumor on the Yahoo Message Board.  South Korea's Ministry of Health and Welfare said the government will invest 33 billion won in stem cell research and regenerative medical treatment this year. This is four times as much as last year's sum. Will the South Koreans buy Geron's stem cell business. I hope so but 33 billion won is only about 30 million dollars. I think they'll be a little short.

Geron closed up 3 cents at $1.56 on 664,553 shares. The three month avg. is 960,623 shares.

Good luck in this rigged casino,

Geron good volume

Geron closed down only 1 cent at $1.51 on 1,942,351 shares. Which is good due to the market sell off. The 3 month avg. volume is 984,558 shares. The good news today would take 5 years to bring to market maybe more.

ACTC was down just a little at 0.0845  on 5.2 million shares the 3 month avg. volume is 16.1 million shares

Good luck in this rigged casino,

Geron receives USPTO patent for CNS-tumor tx

Geron receives USPTO patent for CNS-tumor treatment method. This is good news, Geron is flat at $1.52 while the market is down big time. Geron three month avg. volume is 969,466 shares, ten day avg. 658,532, today's volume is over 1,570,000 shares. Hope for more good news with raise in price.

Good luck in this rigged casino,

Geron and ACTC down

Geron is not holding up well at all. Closed down 6 cents at $1.52 on 579,901 shares, avg. 3 months volume is 984,327 shares. Just waiting for the deal and then results in Dec 12.

ACTC was down just a little on 4.9 million shares avg. 3 months volume was 17 million shares.
With no news and in a down market Geron is not doing well. ACTC is holding up better at least for now.

Good luck is this rigged casino,

ACTC up Appoints Michael Haffeman to BOD

This is good news IMO and the market likes it. ACTC is up a little in a very down market.
I love this line, Michael's expertise in pharmaceutical product development as well as experience in capital markets and deal-making will be invaluable to the company as we continue  our forward momentum with our clinical programs. That is great, meaning they feel they will have a product and they know they will have to make a deal with big pharma

Geron is down not good, no news, no volume, no deal.

Good luck in this rigged casino,

Geron is a deal near?

Rumors on the Yahoo Message Board. Geron will be be spinning off the stem-cell programs, merge with a big pharma company. It will happen by the end of Dec 2012 at the latest or when the Viacyte case is cleared.  The additional 100M shares may have come from negotiations for such a deal.

Geron closed down at $1.58 a share on only 653,280 shares.

Will any of this happen, who knows, by the volume and share price, nothing is happening soon.

Good luck in this rigged casino,

Down Geron and ACTC

I added a few more shares of ACTC  at 0.087. Still think the Phase 1/2 trials will be ground breaking. ACTC closed at 0.0852.

Geron closed down at $1.60. I think the glass is half full, everyone else thinks the glass is broken. The report was good. The imetelstat trials which are driven by doctors trying to help their patients in a desperate situation, over 100 medical facilities have accepted imelestat trials. That is a remarkable indication of interest and support. If the trials have good results it's early retirement, if bad it's working till I drop dead.

Good luck in this rigged casino,

Geron good results with its telomerase inhibitors

I looked at the results on Geron website, not easy read, the results look good. You can check them out for yourself at Geron's website click Investor Relations, click Events, click American Association for Cancer Research click AACR Herbert Poster and Geron AACR Poster. The results were not posted till after the market closed.
Geron closed down two cent at $1.67 on 635,017 shares. Lets see Wednesday if the news of the results move the share price.  It should go up a little.

Good luck in this rigged casino,

Geron presentations Tue on telomerase inhibitors

Geron will present preclinical data related to imetelstat, the company's telomerase inhibitors. April 3rd, the results will be posted on there website. Results must be good. If not why do a presentation. Also they want the ok to be able sell 100 million more share. If results are looking good, the share price will go up and Geron sells some shares. Making money for phase 3 trials. Closed  $1.69 on 868,708 shares. The 10 day avg. volume is 538,615.  The three month avg volume is 1 million shares.
I think the presentation will move this share price up. Lets see if I'm right.

Good luck in this rigged casino,